Catabasis Pharmaceuticals Secures $7,700,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0b53ebc6-9820-41c1-90a3-1da5f7f2ce5d&Preview=1 -
Date
4/15/2010 -
Company Name
Catabasis Pharmaceuticals -
Mailing Address
161 First Street Cambridge, MA 02142 -
Company Description
At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients. -
Website
http://www.catabasispharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$7,700,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
MedImmune Ventures -
Venture Investor
Clarus Ventures -
Venture Investor
SV Life Sciences
